{"database": "lobbying", "table": "lobbying_activities", "rows": [[256591, "9475a520-829d-44c7-a2d6-992e2881aae8", "YY", "ZUCKERMAN SPAEDER LLP", 42160, "BARR LABORATORIES", 2003, "year_end", "MED", "Hatch-Waxman Admendments; biogenerics", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 25000, null, 0, 0, "2004-02-09T00:00:00-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["256591"], "units": {}, "query_ms": 26.15635795518756, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}